Ocaliva is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Intercept Pharmaceuticals Inc. The primary component is Obeticholic Acid.
Product ID | 69516-005_1d6c9e9d-e17d-4609-91fa-75e5bdbc5114 |
NDC | 69516-005 |
Product Type | Human Prescription Drug |
Proprietary Name | Ocaliva |
Generic Name | Obeticholic Acid |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2016-05-27 |
Marketing Category | NDA / NDA |
Application Number | NDA207999 |
Labeler Name | Intercept Pharmaceuticals Inc |
Substance Name | OBETICHOLIC ACID |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Farnesoid X Receptor Agonist [EPC], Farnesoid X Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2016-05-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207999 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-05-27 |
Ingredient | Strength |
---|---|
OBETICHOLIC ACID | 5 mg/1 |
SPL SET ID: | cdfbe0cd-eb15-45a1-ac17-531bcda21aec |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69516-005 | Ocaliva | Obeticholic Acid |
69516-010 | Ocaliva | Obeticholic Acid |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OCALIVA 86710924 5033038 Live/Registered |
INTERCEPT PHARMACEUTICALS, INC. 2015-07-31 |
OCALIVA 86710865 5014396 Live/Registered |
INTERCEPT PHARMACEUTICALS, INC. 2015-07-31 |